Outcomes in Hepatitis C Positive Liver Transplantation: Timing of Direct-Acting Antiviral Treatment and Impact on Graft Fibrosis

Outcomes in Hepatitis C Positive Liver Transplantation: Timing of Direct-Acting Antiviral Treatment and Impact on Graft Fibrosis

Liver transplantation for hepatitis C virus (HCV)-related disease has the lowest five-year graft survival among all liver transplant recipients. Graft failure due to accelerated fibrosis from unrestrained HCV replication is common. Optimal timing of HCV treatment with direct-acting antiviral agents...

Full description

Bibliographic Details
Main Authors: Jennifer Wellington, Andrew Ma, Shyam Kottilil, Bharath Ravichandran, Jennifer Husson, David Bruno, Eleanor Wilson
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Viruses
Subjects:
liver transplant
hepatitis C Virus
graft fibrosis
Online Access:https://www.mdpi.com/1999-4915/13/9/1831

Internet

https://www.mdpi.com/1999-4915/13/9/1831

Similar Items